Alok Kumar Dwivedi

6PUBLICATIONS
29CO-AUTHORS
Molecular targetsHealth promotionCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 05, 2024
First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain-Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors.

Melissa L Johnson, Beni B Wolf, Judy S Wang

|Nov 26, 2024
A holistic approach to sustain and support lifelong practices of wellness among healthcare professionals: generating preliminary solid steps towards a culture of wellness.

Beverley Argus-Calvo, Deborah J Clegg, Maureen D Francis

|Jun 15, 2022
Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer.

Sayed Reshad Ghafouri, Suvarna Guvvala, Catherine Jones

|Dec 24, 2021
Novel Combinatorial Strategy Using Thermal Inkjet Bioprinting, Chemotherapy, and Radiation on Human Breast Cancer Cells; an In-Vitro Cell Viability Assessment.

Aleli Campbell, Denisse A Gutierrez, Colin Knight

|Sep 29, 2020
Remarkable response to combined immunochemotherapy in patients with metastatic triple-negative breast cancer.

Alexander Philipovskiy, Karinn Chambers, Ioannis Konstantinidis

|Sep 04, 2020
Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer.

Alexander Philipovskiy, Alok K Dwivedi, Roberto Gamez

Pageof 1

Frequent Collaborators

1 joint publications

Colin Knight

1 joint publications

Charlotte M Vines

1 joint publications

Armando Varela-Ramirez

1 joint publications

Thomas Boland